Healthcare provider profile · identity verified

David E Overare, MD

Family Practice · ERIE, PA · NPI 1063490274

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	713	190
Pantoprazole Sodium	Pantoprazole Sodium	462	117
Levothyroxine Sodium	Levothyroxine Sodium	446	91
Amlodipine Besylate	Amlodipine Besylate	432	100
Albuterol Sulfate Hfa	Albuterol Sulfate	315	75
Gabapentin	Gabapentin	308	55
Potassium Chloride	Potassium Chloride	271	46
Metoprolol Succinate	Metoprolol Succinate	269	67
Tamsulosin Hcl	Tamsulosin Hcl	239	53
Lisinopril	Lisinopril	229	65
Omeprazole	Omeprazole	221	58
Losartan Potassium	Losartan Potassium	212	49
Metformin Hcl Er	Metformin Hcl	205	57
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	188	29
Furosemide	Furosemide	173	36
Mounjaro	Tirzepatide	172	33
Meloxicam	Meloxicam	163	37
Rosuvastatin Calcium	Rosuvastatin Calcium	155	41
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	152	48
Hydrochlorothiazide	Hydrochlorothiazide	151	39
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	147	37
Metformin Hcl	Metformin Hcl	136	29
Clopidogrel	Clopidogrel Bisulfate	134	36
Metoprolol Tartrate	Metoprolol Tartrate	134	32
Simvastatin	Simvastatin	131	33
Duloxetine Hcl	Duloxetine Hcl	129	23
Fluticasone Propionate	Fluticasone Propionate	125	33
Eliquis	Apixaban	123	23
Lorazepam	Lorazepam	120	28
Sertraline Hcl	Sertraline Hcl	116	32
Trazodone Hcl	Trazodone Hcl	116	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	112	27
Tramadol Hcl	Tramadol Hcl	103	18
Famotidine	Famotidine	99	25
Atenolol	Atenolol	96	25
Alendronate Sodium	Alendronate Sodium	91	22
Jardiance	Empagliflozin	91	23
Finasteride	Finasteride	90	21
Pravastatin Sodium	Pravastatin Sodium	88	21
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	85	24
Allopurinol	Allopurinol	83	19
Ventolin Hfa	Albuterol Sulfate	80	19
Diclofenac Sodium	Diclofenac Sodium	75	29
Tizanidine Hcl	Tizanidine Hcl	74	12
Mirtazapine	Mirtazapine	73	16
Ozempic	Semaglutide	73	14
Ondansetron Odt	Ondansetron	69	15
Pregabalin	Pregabalin	69	15
Citalopram Hbr	Citalopram Hydrobromide	68	suppressed
Prednisone	Prednisone	67	57
Synthroid	Levothyroxine Sodium	66	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	65	11
Azithromycin	Azithromycin	64	61
Naproxen	Naproxen	64	18
Ezetimibe	Ezetimibe	63	15
Donepezil Hcl	Donepezil Hcl	62	15
Memantine Hcl	Memantine Hcl	62	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	61	17
Fenofibrate	Fenofibrate Nanocrystallized	56	14
Fluoxetine Hcl	Fluoxetine Hcl	56	15
Meclizine Hcl	Meclizine Hcl	56	17
Trulicity	Dulaglutide	56	12
Montelukast Sodium	Montelukast Sodium	55	17
Klor-Con M20	Potassium Chloride	51	14
Escitalopram Oxalate	Escitalopram Oxalate	49	14
Levetiracetam	Levetiracetam	49	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	46	suppressed
Spiriva Respimat	Tiotropium Bromide	46	suppressed
Alprazolam	Alprazolam	45	suppressed
Spironolactone	Spironolactone	45	11
Baclofen	Baclofen	43	11
Xarelto	Rivaroxaban	43	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	32
Hydroxyzine Hcl	Hydroxyzine Hcl	40	suppressed
Linzess	Linaclotide	40	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	39	suppressed
Oxycodone Hcl	Oxycodone Hcl	39	suppressed
Paroxetine Hcl	Paroxetine Hcl	39	suppressed
Ibuprofen	Ibuprofen	37	15
Celecoxib	Celecoxib	35	suppressed
Cephalexin	Cephalexin	35	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	17
Bupropion Xl	Bupropion Hcl	34	suppressed
Clonazepam	Clonazepam	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	32
Sucralfate	Sucralfate	32	suppressed
Enalapril Maleate	Enalapril Maleate	31	suppressed
Incruse Ellipta	Umeclidinium Bromide	31	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	31	suppressed
Tradjenta	Linagliptin	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	11
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Mupirocin	Mupirocin	29	19
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	29	suppressed
Amoxicillin	Amoxicillin	25	21
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	25	18
Farxiga	Dapagliflozin Propanediol	25	suppressed
Glimepiride	Glimepiride	25	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	24	suppressed
Carvedilol	Carvedilol	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	24	23
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Topiramate	Topiramate	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Diazepam	Diazepam	22	suppressed
Fluconazole	Fluconazole	22	15
Gemfibrozil	Gemfibrozil	22	suppressed
Methocarbamol	Methocarbamol	22	suppressed
Labetalol Hcl	Labetalol Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Risperidone	Risperidone	19	suppressed
Glipizide	Glipizide	18	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	18	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	16
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Klor-Con M10	Potassium Chloride	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Armour Thyroid	Thyroid,pork	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Valsartan	Valsartan	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Cefdinir	Cefdinir	14	12
Doxepin Hcl	Doxepin Hcl	14	suppressed
Eletriptan Hbr	Eletriptan Hydrobromide	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Lumigan	Bimatoprost	14	suppressed
Nystatin	Nystatin	14	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Toprol Xl	Metoprolol Succinate	12	suppressed
Veozah	Fezolinetant	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error